1. Home
  2. CPF vs EVO Comparison

CPF vs EVO Comparison

Compare CPF & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Pacific Financial Corp New

CPF

Central Pacific Financial Corp New

HOLD

Current Price

$38.29

Market Cap

997.1M

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.79

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPF
EVO
Founded
1954
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
997.1M
1.0B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
CPF
EVO
Price
$38.29
$2.79
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$37.00
$7.00
AVG Volume (30 Days)
156.6K
26.4K
Earning Date
04-29-2026
04-08-2026
Dividend Yield
3.39%
N/A
EPS Growth
45.18
N/A
EPS
0.78
N/A
Revenue
$51,817,000.00
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
$4.62
$10.05
P/E Ratio
$48.91
N/A
Revenue Growth
33.81
N/A
52 Week Low
$25.62
$2.31
52 Week High
$39.20
$4.42

Technical Indicators

Market Signals
Indicator
CPF
EVO
Relative Strength Index (RSI) 63.35 48.47
Support Level $33.33 $2.60
Resistance Level $39.20 $2.93
Average True Range (ATR) 0.89 0.07
MACD -0.01 0.02
Stochastic Oscillator 76.72 54.52

Price Performance

Historical Comparison
CPF
EVO

About CPF Central Pacific Financial Corp New

Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services. It operates in single segment which is Banking operations.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: